Quote Lookup

Please enter a ticker symbol below and click Submit.
Symbol:        VL Survey Page (2014-03-14)Premium Content

Alkermes Plc (ALKS)

2014-04-15@12:29:50 ET
Alkermes Shares Climbing Higher, Up 1.7% (F77)

2014-04-15@11:16:09 ET
Alkermes (ALKS) Showing Bearish Technicals (FBM)

2014-04-14@18:17:50 ET
Watch for Alkermes to Potentially Rebound After Falling 1.43% Yesterday (PSM)

2014-04-14@11:13:33 ET
Alkermes (ALKS) Showing Bearish Technicals With Resistance At $44.58 (FBM)

2014-04-12@06:36:10 ET
Form 4: Update Filing for Alkermes PLC (ALKS) (VKR)

2014-04-11@10:14:00 ET
Priority Reviews, Preliminary Earnings Releases, Clinical Trials Results, and Launch of Website - Analyst Notes on Gilead, Pfizer, Intuitive Surgical, Alkermes and Quest (PRN)

2014-04-11@00:56:20 ET
Alkermes Issues Positive Phase 3 Study Results (CLM)

2014-04-10@12:48:44 ET
Potential Alkermes (ALKS) Trade Has 6.41% Downside Protection (FBM)

2014-04-10@12:23:00 ET
Certifications, Authorizations, Stock Updates, and Upcoming Conferences - Analyst Notes on Edwards Lifesciences, Alkermes, ResMed, Auxilium, and Teleflex (PRN)

2014-04-10@08:03:41 ET
Upgrade Alert for Alkermes (ALKS) (PSM)

2014-04-10@08:01:19 ET
Top 5 Companies in the Biotechnology Industry with the Best Relative Performance (CYTK, CLDX, ISIS, ALKS, VRTX) (F70)

2014-04-10@07:13:12 ET
Alkermes announces positive results from Phase III schizophrenia trial (DTM)

2014-04-10@07:10:58 ET
Oncolytics Reports Additional Data on Reolysin (ZAX)

2014-04-09@14:52:33 ET
Alkermes (ALKS) Trading Near $46.79 Resistance Level (FBM)

2014-04-04@13:08:32 ET
Shares of Alkermes Under Pressure, Down 7.3% (F77)

2014-04-04@10:20:32 ET
Potential Alkermes (ALKS) Trade Has 9.90% Downside Protection (FBM)

2014-04-03@23:53:30 ET
US Patent Issued to Alkermes Pharma Ireland on April 1 for "Prodrugs of NH-acidic compounds" (Massachusetts Inventors) (ABW)

2014-04-03@11:28:52 ET
Form 4: Update Filing for Alkermes PLC (ALKS) (VKR)